Literature DB >> 12695554

Expression profiling of osteosarcoma cells transfected with MDR1 and NEO genes: regulation of cell adhesion, apoptosis, and tumor suppression-related genes.

Marta Sanchez-Carbayo1, Thomas J Belbin, Katia Scotlandi, Michael Prystowsky, Nicola Baldini, Geoffrey Childs, Carlos Cordon-Cardo.   

Abstract

The expression patterns of the osteosarcoma cell line U-2 OS, and three derived subclones containing stably transfected MDR1, NEO and MDR1/NEO genes were compared using cDNA microarrays comprising 8976 known genes and expressed sequenced tags. Data provided new insights into three critical issues. First, MDR1 overexpression was associated with altered expression of genes related to several cellular pathways, including (a). drug influx/efflux (eg, dynamin 3), (b). metabolic enzymes (eg, monoamine oxidase A), (c). cell adhesion (eg, EPCAM), (d). apoptotic signaling (eg, I-TRAF), (e). senescence (eg, telomerase RNA binding protein staufen), (f). tumor suppression-related genes (eg, KISS-1 and ephrin B3), and (g). immune system receptors (eg, LENG2). MDR1, EPCAM, and ephrin B3 expression was confirmed by immunohistochemistry. Second, MDR1 transfected cells selected with either doxorubicin or neomycin showed distinct expression profiles that could be related to differential selection. Moreover, hierarchical clustering indicated that cells transfected with MDR1 alone, or cotransfected with NEO, displayed more closely related expression profiles than cells transfected only with NEO. Third, transfection with NEO and selection with neomycin produced a considerable number of expression changes within the cell. This study further elucidates the genetic events associated with MDR1 expression and identifies novel targets associated with multidrug resistance.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12695554     DOI: 10.1097/01.lab.0000064702.63200.94

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  11 in total

Review 1.  International Union of Basic and Clinical Pharmacology. LXXVII. Kisspeptin receptor nomenclature, distribution, and function.

Authors:  Helen R Kirby; Janet J Maguire; William H Colledge; Anthony P Davenport
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

Review 2.  Disrupting P-glycoprotein function in clinical settings: what can we learn from the fundamental aspects of this transporter?

Authors:  Francisco S Chung; Jayson S Santiago; Miguel Francisco M De Jesus; Camille V Trinidad; Melvin Floyd E See
Journal:  Am J Cancer Res       Date:  2016-08-01       Impact factor: 6.166

3.  Q36R polymorphism of KiSS-1 gene in Brazilian head and neck cancer patients.

Authors:  Mariângela Torreglosa Ruiz; Ana Lívia Silva Galbiatti; Erika Cristina Pavarino; José Victor Maniglia; Eny Maria Goloni-Bertollo
Journal:  Mol Biol Rep       Date:  2012-01-01       Impact factor: 2.316

4.  Regulation of embryonic kidney branching morphogenesis and glomerular development by KISS1 receptor (Gpr54) through NFAT2- and Sp1-mediated Bmp7 expression.

Authors:  Tingfang Yi; Kunrong Tan; Sung-Gook Cho; Ying Wang; Jian Luo; Wenzheng Zhang; Dali Li; Mingyao Liu
Journal:  J Biol Chem       Date:  2010-04-07       Impact factor: 5.157

5.  Epithelial cell adhesion molecule is expressed in a subset of sarcomas and correlates to the degree of cytological atypia in leiomyosarcomas.

Authors:  Kristi Ward; Clarissa Amaya; Kundan Verma; Dat Tran; Dolores Diaz; Alireza Torabi; Brad A Bryan
Journal:  Mol Clin Oncol       Date:  2014-09-25

6.  Mice lacking multidrug resistance protein 1a show altered dopaminergic responses to methylenedioxymethamphetamine (MDMA) in striatum.

Authors:  Karl B Scheidweiler; Bruce Ladenheim; Jean Lud Cadet; Marilyn A Huestis
Journal:  Neurotox Res       Date:  2009-10-23       Impact factor: 3.911

Review 7.  Diagnostic and prognostic sarcoma signatures.

Authors:  Elai Davicioni; Daniel H Wai; Michael J Anderson
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

8.  Kisspeptin-10, a KISS1-derived decapeptide, inhibits tumor angiogenesis by suppressing Sp1-mediated VEGF expression and FAK/Rho GTPase activation.

Authors:  Sung-Gook Cho; Zhengfang Yi; Xiufeng Pang; Tingfang Yi; Ying Wang; Jian Luo; Zirong Wu; Dali Li; Mingyao Liu
Journal:  Cancer Res       Date:  2009-08-11       Impact factor: 12.701

Review 9.  Kisspeptins: a multifunctional peptide system with a role in reproduction, cancer and the cardiovascular system.

Authors:  E J Mead; J J Maguire; R E Kuc; A P Davenport
Journal:  Br J Pharmacol       Date:  2007-05-21       Impact factor: 8.739

Review 10.  Kisspeptin/KISS1R System in Breast Cancer.

Authors:  Donna Cvetković; Andy V Babwah; Moshmi Bhattacharya
Journal:  J Cancer       Date:  2013-09-26       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.